Les manifestations rénales de la spondylarthrite ankylosante : à propos de 210 cas

Taarit, C. Ben; Ajlani, H.; Moussa, F. Ben; Abdallah, T. Ben; Maı̈z, H. Ben; Khedher, A.

doi:10.1016/j.revmed.2005.07.017

Cited by 20 publications

(15 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although renal involvement is recognised in ankylosing spondylitis [10], we see no connection between the patients' concomitant condition and RPH, the hematoma here representing a purely mechanical injury. We likewise found no connection to endomyocardial biopsy or DCM in an extensive search of the literature.…”

Section: Discussioncontrasting

confidence: 57%

Renal perforation and retroperitoneal hematoma: an unusual complication following cardiac catheterization

Peters

Yazar

Lemburg

et al. 2007

Int J Cardiovasc Imaging

View full text Add to dashboard Cite

Retroperitoneal hematoma (RPH) is a well-recognised, albeit rare complication of percutaneous transfemoral cardiac catheterization. We describe an unusual case of renal perforation and RPH following transfemoral cardiac catheterization for endomyocardial biopsy. Diagnosis was made based on multidetector computed tomography (MDCT) which clearly depicted active renal hemorrhage in short acquisition time. The case expands the spectrum of possible complications of percutaneous transfemoral cardiac catheterization and illustrates the usefulness MDCT in quickly and adequately detecting RPH.

show abstract

Section: Discussioncontrasting

confidence: 57%

Renal perforation and retroperitoneal hematoma: an unusual complication following cardiac catheterization

Peters

Yazar

Lemburg

et al. 2007

Int J Cardiovasc Imaging

View full text Add to dashboard Cite

show abstract

“…Therefore, mutations in exon 10 of MEFV may not be as rare as we previously thought, and more related investigations are needed to verify this point. Secondary amyloidosis is the most severe complication of FMF and occurs in AS patients [ 47 – 50 ]. Additionally, subclinical amyloidosis has been detected in 6.9% of ankylosing spondylitis patients [ 51 ], and those who died of secondary amyloidosis account for 12.5% of the total deaths [ 52 ].…”

Section: Discussionmentioning

confidence: 99%

MEFV M694V mutation has a role in susceptibility to ankylosing spondylitis: A meta-analysis

et al. 2017

View full text Add to dashboard Cite

ObjectiveThe aim of the current study was to determine the contributions of several common mutations in the Mediterranean fever (MEFV) gene, namely, E148Q, M680I, M694V and V726A, to ankylosing spondylitis (AS) susceptibility.MethodsTwo investigators independently searched the literature regarding the association of MEFV with AS in the PubMed, EMBASE, Web of Science, and Scopus databases. They independently selected eligible articles and then extracted data from the included studies. The associations between MEFV mutations and AS risk were assessed with odds ratios (ORs) and 95% confidence intervals (95% CI). Further analyses were conducted with STATA 12.0 software (Stata Corp.; College Station, Texas, USA).ResultsFour mutations (E148Q, M680I, M694V and V726A) were genotyped in 869 AS cases and 879 controls from the 8 eligible studies. Of the four mutations, M694V (pooled OR: 3.330, 95% CI: 2.129–5.208) was found to be associated with AS through overall analysis. However, the other mutations demonstrated no relation with AS (pooled ORs: 1.295, 1.258, 1.778; 95% CI: 0.886–1.891, 0.688–2.298 and 0.938–3.371). No significant publication bias was discovered in the meta-analysis.ConclusionsThe present study indicates that the MEFV M694V mutation may contribute to the pathogenesis of AS. The associations between the other mutations and AS need to be validated with more relevant and well-designed studies.

show abstract

“…Renal involvement among AS patients was reported as high as 13.3% [ 10 – 12 ]. Therefore, patients with AS should be regularly monitored for renal complications.…”

Section: Discussionmentioning

confidence: 99%

“…Renal involvement is a rare but important complication that is mostly discounted in young patients. Renal complications are estimated to occur in 8%–13.3% of patients with ankylosing spondylitis (AS) [ 9 , 10 ]. Microscopic hematuria, proteinuria, increased serum creatinine, and nephrotic syndrome are major manifestations, and secondary amyloid A amyloidosis (62%) and immunoglobulin A (IgA) nephropathy (30%) are the two most frequently reported causes of renal involvement [ 11 , 12 ].…”

Section: Introductionmentioning

confidence: 99%

Axial Spondyloarthritis and Autosomal Dominant Polycystic Kidney Disease in Two Siblings: A Rare Cooccurrence

Yurdakul

Tamer

Küçükakkaş

et al. 2018

Case Reports in Rheumatology

View full text Add to dashboard Cite

Autosomal dominant polycystic kidney disease (ADPKD) is the most frequently occurring hereditary kidney disease, and axial spondyloarthritis (SpA) is one of the most frequently occurring rheumatic diseases. Treatment-related decisions for axial SpA may pose a challenge in case of renal involvement. The authors describe two siblings with cooccurrence of these two diseases. The association of these two diseases is not well known. Practitioners should monitor renal function in SpA patients and take treatment-related decisions regarding renal involvement. Antitumor necrosis factor-alpha (anti-TNF-α) agents may be used in case nonsteroidal anti-inflammatory drugs (NSAIDs) cannot be utilized.

show abstract

Les manifestations rénales de la spondylarthrite ankylosante : à propos de 210 cas

Cited by 20 publications

References 12 publications

Renal perforation and retroperitoneal hematoma: an unusual complication following cardiac catheterization

Renal perforation and retroperitoneal hematoma: an unusual complication following cardiac catheterization

MEFV M694V mutation has a role in susceptibility to ankylosing spondylitis: A meta-analysis

Axial Spondyloarthritis and Autosomal Dominant Polycystic Kidney Disease in Two Siblings: A Rare Cooccurrence

Contact Info

Product

Resources

About